Short Interest in WisdomTree BioRevolution Fund (BATS:WDNA) Expands By 102.7%

WisdomTree BioRevolution Fund (BATS:WDNAGet Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,563 shares, an increase of 102.7% from the April 30th total of 2,744 shares. Based on an average daily volume of 950 shares, the days-to-cover ratio is presently 5.9 days. Approximately 3.7% of the shares of the company are sold short.

WisdomTree BioRevolution Fund Price Performance

WDNA stock opened at $17.64 on Wednesday. The company has a fifty day moving average price of $17.72 and a two-hundred day moving average price of $17.63. WisdomTree BioRevolution Fund has a one year low of $12.49 and a one year high of $18.88. The stock has a market cap of $2.65 million, a price-to-earnings ratio of 17.03 and a beta of 1.01.

Institutional Investors Weigh In On WisdomTree BioRevolution Fund

An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC lifted its position in shares of WisdomTree BioRevolution Fund (BATS:WDNAFree Report) by 59.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,182 shares of the company’s stock after buying an additional 9,720 shares during the quarter. Flow Traders U.S. LLC owned about 17.45% of WisdomTree BioRevolution Fund worth $416,000 as of its most recent SEC filing.

WisdomTree BioRevolution Fund Company Profile

(Get Free Report)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.

Read More

Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.